210 related articles for article (PubMed ID: 12111346)
21. Airborne concentrations, skin contamination, and urinary metabolite excretion of polycyclic aromatic hydrocarbons among paving workers exposed to coal tar derived road tars.
Jongeneelen FJ; Scheepers PT; Groenendijk A; Van Aerts LA; Anzion RB; Bos RP; Veenstra SJ
Am Ind Hyg Assoc J; 1988 Dec; 49(12):600-7. PubMed ID: 3213813
[TBL] [Abstract][Full Text] [Related]
22. Topical tar: back to the future.
Paghdal KV; Schwartz RA
J Am Acad Dermatol; 2009 Aug; 61(2):294-302. PubMed ID: 19185953
[TBL] [Abstract][Full Text] [Related]
23. Final safety assessment of Coal Tar as used in cosmetics.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 2():1-24. PubMed ID: 18830861
[TBL] [Abstract][Full Text] [Related]
24. Biological monitoring of human exposure to coal tar. Urinary excretion of total polycyclic aromatic hydrocarbons, 1-hydroxypyrene and mutagens in psoriatic patients.
Clonfero E; Zordan M; Venier P; Paleologo M; Levis AG; Cottica D; Pozzoli L; Jongeneelen FJ; Bos RP; Anzion RB
Int Arch Occup Environ Health; 1989; 61(6):363-8. PubMed ID: 2744865
[TBL] [Abstract][Full Text] [Related]
25. An evidence-based review of the efficacy of coal tar preparations in the treatment of psoriasis and atopic dermatitis.
Slutsky JB; Clark RA; Remedios AA; Klein PA
J Drugs Dermatol; 2010 Oct; 9(10):1258-64. PubMed ID: 20941951
[TBL] [Abstract][Full Text] [Related]
26. Incidence of skin cancers in patients with atopic dermatitis treated with ocal tar. A 25-year follow-up study.
Maughan WZ; Muller SA; Perry HO; Pittelkow MR; O'Brien PC
J Am Acad Dermatol; 1980 Dec; 3(6):612-5. PubMed ID: 7204678
[TBL] [Abstract][Full Text] [Related]
27. No increased risk of cancer after coal tar treatment in patients with psoriasis or eczema.
Roelofzen JH; Aben KK; Oldenhof UT; Coenraads PJ; Alkemade HA; van de Kerkhof PC; van der Valk PG; Kiemeney LA
J Invest Dermatol; 2010 Apr; 130(4):953-61. PubMed ID: 20016499
[TBL] [Abstract][Full Text] [Related]
28. Targeting the Cutaneous Microbiota in Atopic Dermatitis by Coal Tar via AHR-Dependent Induction of Antimicrobial Peptides.
Smits JPH; Ederveen THA; Rikken G; van den Brink NJM; van Vlijmen-Willems IMJJ; Boekhorst J; Kamsteeg M; Schalkwijk J; van Hijum SAFT; Zeeuwen PLJM; van den Bogaard EH
J Invest Dermatol; 2020 Feb; 140(2):415-424.e10. PubMed ID: 31344386
[TBL] [Abstract][Full Text] [Related]
29. Biological monitoring of human exposure to coal tar. Urinary mutagenicity assays and analytical determination of polycyclic aromatic hydrocarbon metabolites in urine.
Clonfero E; Jongeneelen F; Zordan M; Levis AG
IARC Sci Publ; 1990; (104):215-22. PubMed ID: 2228119
[TBL] [Abstract][Full Text] [Related]
30. 1-Hydroxypyrene levels in coal-handling workers at a coke oven.
Malkin R; Kiefer M; Tolos W
J Occup Environ Med; 1996 Nov; 38(11):1141-4. PubMed ID: 8941904
[TBL] [Abstract][Full Text] [Related]
31. Acute severe bronchoconstriction precipitated by coal tar bandages.
Ibbotson SH; Stenton SC; Simpson NB
Clin Exp Dermatol; 1995 Jan; 20(1):58-9. PubMed ID: 7671400
[TBL] [Abstract][Full Text] [Related]
32. Nonselective and selective methods for biological monitoring of exposure to coal-tar products.
Bos RP; Jongeneelen FJ
IARC Sci Publ; 1988; (89):389-95. PubMed ID: 3198226
[TBL] [Abstract][Full Text] [Related]
33. Chromosomal alterations in peripheral blood lymphocytes, urinary mutagenicity and excretion of polycyclic aromatic hydrocarbons in six psoriatic patients undergoing coal tar therapy.
Sarto F; Zordan M; Tomanin R; Mazzotti D; Canova A; Cardin EL; Bezze G; Levis AG
Carcinogenesis; 1989 Feb; 10(2):329-34. PubMed ID: 2643486
[TBL] [Abstract][Full Text] [Related]
34. [The aryl hydrocarbon receptor as the target structure for new drugs in psoriasis and atopic dermatitis].
Merk HF
Hautarzt; 2019 Dec; 70(12):942-947. PubMed ID: 31728551
[TBL] [Abstract][Full Text] [Related]
35. Skin disease after occupational dermal exposure to coal tar: a review of the scientific literature.
Moustafa GA; Xanthopoulou E; Riza E; Linos A
Int J Dermatol; 2015 Aug; 54(8):868-79. PubMed ID: 26183242
[TBL] [Abstract][Full Text] [Related]
36. Urinary mutagenicity and genotoxic risk in children with psoriasis after therapeutic exposure to polycyclic aromatic hydrocarbons and ultraviolet radiation.
Borska L; Smejkalova J; Cerna M; Hamakova K; Kucera I; Kremlacek J; Pelikanova D; Fiala Z
Mutat Res; 2010 Feb; 696(2):144-7. PubMed ID: 20096371
[TBL] [Abstract][Full Text] [Related]
37. Influence of metabolic genotype GSTM1 on levels of urinary mutagens in patients treated topically with coal tar.
Gabbani G; Pavanello S; Nardini B; Tognato O; Bordin A; Fornasa CV; Bezze G; Clonfero E
Mutat Res; 1999 Mar; 440(1):27-33. PubMed ID: 10095126
[TBL] [Abstract][Full Text] [Related]
38. The relationship between polycyclic aromatic hydrocarbons in air and in urine of workers in a Söderberg potroom.
Tjoe Ny E; Heederik D; Kromhout H; Jongeneelen F
Am Ind Hyg Assoc J; 1993 Jun; 54(6):277-84. PubMed ID: 8328359
[TBL] [Abstract][Full Text] [Related]
39. Dermal uptake of polycyclic aromatic hydrocarbons after hairwash with coal-tar shampoo.
van Schooten FJ; Moonen EJ; Rhijnsburger E; van Agen B; Thijssen HH; Kleinjans JC
Lancet; 1994 Nov; 344(8935):1505-6. PubMed ID: 7968140
[No Abstract] [Full Text] [Related]
40. Carcinogenic consequences of coal-tar shampoo?
van Schooten FJ
Lancet; 1995 Jun; 345(8965):1635. PubMed ID: 7783550
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
